|
621 |
Contribution from Malaysia facility can only come in FY16 |
Download (160.79 KB)  |
24/01/2014 |
|
622 |
Eli Lilly testing pricing model in India |
Download (198.16 KB) |
23/01/2014 |
|
623 |
Alembic Pharma reports loss |
Download (44.69 KB) |
23/01/2014 |
|
624 |
Torrent Pharma shares up 8% |
Download (96.44 KB) |
23/01/2014 |
|
625 |
Seven unit gets recognition in US |
Download (66 KB) |
23/01/2014 |
|
626 |
Torrent pharma Q3 standalone net up 36% |
Download (114.02 KB) |
22/01/2014 |
|
627 |
Aurobindo European prospects brighten |
Download (229.21 KB) |
22/01/2014 |
|
628 |
Cadila gets USFDA nod for drugs |
Download (53.69 KB) |
22/01/2014 |
|
629 |
Sameer goel in india head of cipla |
Download (112.49 KB) |
21/01/2014 |
|
630 |
Sun pharma eyes Rs 8000-crore acquisitions in US Europe |
Download (141.91 KB) |
21/01/2014 |
|
631 |
Cadila Healthcare Rs 870.2 |
Download (77.47 KB) |
12/01/2014 |
|
632 |
Dr. Reddy to market optidoz an anti-hypertension drug |
Download (98.19 KB) |
12/01/2014 |
|
633 |
Kopran lines up 15 products in 2014 |
Download (58.39 KB) |
04/01/2014 |
|
634 |
GSK Pharma rallies 21% after open offer |
Download (126.72 KB) |
04/01/2014 |
|
635 |
Biocon chief executive contender bamzai quits |
Download (163.12 KB) |
03/01/2014 |
|
636 |
Novartis india strikes large office space deal in cyberabad |
Download (101.52 KB) |
03/01/2014 |
|
637 |
Buy Aurobindo pharma on better earnings |
Download (84.95 KB) |
03/01/2014 |
|
638 |
Luping up on US FDA nod for generic |
Download (52.33 KB) |
02/01/2014 |
|
639 |
Ranbaxy turns focus to domestic market |
Download (195.16 KB) |
02/01/2014 |
|
640 |
Lupin Cipla gain on drug approvals |
Download (93.29 KB) |
02/01/2014 |
औषध विभाग
Department of
